Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Duret

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
RMD Open|November 9, 2023
Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2-5 and MAXIMISE studiesRenaud Felten, Laura Widawski, Lionel Spielmann, et al.
Medecine Sciences : M/S|October 14, 2021
[Which taxonomy for inflammatory diseases in rheumatology? The concept of Psout]Laurent Messer, Renaud Felten, Pierre-Marie Duret, et al.
Arthritis Research & Therapy|February 26, 2020
Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndromePierre-Marie Duret, Nicolas Meyer, Alain Saraux, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 28, 2023
Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's SyndromePierre-Marie Duret, Cedric Schleiss, Lou Kawka, et al.
Joint Bone Spine|May 1, 2022
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritidesRenaud Felten, Marion Geoffroy, Loïs Bolko, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
Annals of the Rheumatic Diseases|September 24, 2021
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Pierre-Marie Duret, Elodie Bauer, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
RMD Open|November 9, 2023
Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2-5 and MAXIMISE studiesRenaud Felten, Laura Widawski, Lionel Spielmann, et al.
Medecine Sciences : M/S|October 14, 2021
[Which taxonomy for inflammatory diseases in rheumatology? The concept of Psout]Laurent Messer, Renaud Felten, Pierre-Marie Duret, et al.
Arthritis Research & Therapy|February 26, 2020
Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndromePierre-Marie Duret, Nicolas Meyer, Alain Saraux, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 28, 2023
Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's SyndromePierre-Marie Duret, Cedric Schleiss, Lou Kawka, et al.
Joint Bone Spine|May 1, 2022
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritidesRenaud Felten, Marion Geoffroy, Loïs Bolko, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
Annals of the Rheumatic Diseases|September 24, 2021
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Pierre-Marie Duret, Elodie Bauer, et al.
Pageof 2